Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001193125-25-321122

Chief Scientific Officer sold 3,143 shares at an average $12.23 ($38,433)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Michaelson Jennifer · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-12 Sale : show line 1 in the form 10b5-1 −2,148 $12.38 $26,592 137,873 D
2025-12-15 Sale : show line 2 in the form 10b5-1 −995 $11.90 $11,841 136,878 D
Open-market sales · 3,143 sh · avg $12.23 · $38,433
Loading xslF345X05/ownership.xml…